The nation of Zimbabwe has rejected a major US health deal valued at 367 million US dollars (£272m) spanning five years due to Washington's demand for sensitive information.
This rejection came to light following a internal memorandum from December was disclosed, revealing that President Emmerson Mnangagwa believed the deal was "unbalanced".
A government spokesperson has since stated that the United States was demanding access to health data for research and profit but was unwilling to guarantee the resulting advantages from future treatments.
"We will now turn to the difficult and regrettable process of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had furnished over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has urged more dialogue to secure a agreement acceptable to both sides so the country's critical HIV treatment initiative can be sustained.
Broader Background
This development follows a similar situation in Kenya, where a court suspended a similar health funding agreement following legal challenges were raised about the safety of Kenyans' health data.
After resuming the presidency recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
The agency had overseen aid for the US government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral agreements to enhance openness and accountability.
According to statements, Sixteen African countries have so far agreed to these new agreements, representing over $18.3bn of fresh investment.
Details of the Rejected Deal
This assistance for Zimbabwe would have funded "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration might have yielded immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy through American-funded programmes," Tremont commented.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to share its genetic material and health information indefinitely, without any equivalent assurance of benefiting from any medical innovations – such as new medicines or tests – that might be developed from that shared data," he stated.
"In essence, our nation would supply the basic resources for scientific discovery without any certainty that the end products would be available to our people should a future disease outbreak emerge."
Sovereignty and International Frameworks
Mangwana further noted that the US's withdrawal from the global health body and its push of bilateral deals were disrupting structures previously set up via the international organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to manage future pandemics.
"This framework is intended to ensure that when a nation contributes its data, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to develop them."
The government's concerns regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We welcome continued dialogue with our US partners on how subsequent collaboration might be structured in a manner that honours the sovereignty and dignity of both nations."
Medical Community Reaction
Medical experts said it understood the official position, but urged that talks should continue given that a large portion of the nation's Aids initiatives depended on international support.
"Where technical issues arise, including those relating to data governance or implementation frameworks, these can frequently be addressed via technical clarification and negotiated safeguards," the group commented.
This impasse emphasises the continuing challenges between receiving crucial foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.